相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Properties of FDA-approved small molecule protein kinase inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Antibody-drug conjugates for cancer
Cindy H. Chau et al.
LANCET (2019)
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement
Laura A. Levit et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Three-point plan for reproducibility
E. Andrew Balas et al.
NATURE (2017)
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C. Dueck et al.
JAMA ONCOLOGY (2015)
The Future of Preclinical Animal Models in Pharmaceutical Discovery and Development: A Need to Bring In Cerebro to the In Vivo Discussions
Jeffrey I. Everitt
TOXICOLOGIC PATHOLOGY (2015)
Evaluation of the Value of Attribution in the Interpretation of Adverse Event Data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group Investigation
Shauna L. Hillman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Concordance of the toxicity of pharmaceuticals in humans and in animals
H Olson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2000)
分享论文
